previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP01256 | 1 | BA_1232 | 30255181 | fabI | enoyl-(acyl-carrier-protein) reductase | 256 | Drug Target Function | March 2008 | 2QIO | 100% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01192 | 1 | BA_1184 | 34098435 | 3-oxoacyl-[acyl-carrier-protein] synthas... | 310 | Drug Target Function | March 2008 | 1ZOW | 61.6% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00816 | 1 | SACOL2061 | 57284929 | acpS | holo-(acyl-carrier-protein) synthase | 119 | Drug Target Function | March 2008 | 3F09 | 100% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01439 | 1 | VC2019 | 15642021 | 3-oxoacyl-(acyl carrier protein) synthas... | 414 | Drug Target Function | March 2008 | 1B3N | 74.9% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01221 | 1 | BA_3990 | 30258499 | fabD | malonyl CoA-acyl carrier protein transac... | 314 | Drug Target Function | March 2008 | 1MLA | 44.9% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP02057 | 1 | Cj1311 | 6968737 | fabH2 | putative 3-oxoacyl-[acyl-carrier-protein... | 232 | N/A | June 2008 | 1QWJ | 26.3% | Campylobacter jejuni | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01193 | 1 | BA_1185 | 30254899 | fabF | 3-oxoacyl-(acyl-carrier-protein) synthas... | 412 | Drug Target Function | March 2008 | 2GQD | 64.8% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01214 | 1 | BA_3460 | 30257999 | cfa | cyclopropane-fatty-acyl-phospholipid syn... | 390 | Drug Target Function | March 2008 | 1TPY | 25.1% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00116 | 1 | NT01ST0285 | 16763622 | accA | acetylCoA carboxylase, carboxytransferas... | 319 | Essential | October 2007 | 2F9Y | 96.9% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01025 | 1 | STM1196 | 16764551 | acpP | acyl carrier protein | 78 | Conserved Gene / Pathway | March 2008 | 1L0H | 100% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP02130 | 1 | Cj1416c | 6968835 | Cj1406c | putative periplasmic protein [Campylobac... | 253 | N/A | June 2008 | 2GGO | 25.7% | Campylobacter jejuni | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00485 | 1 | YPO1455 | 16121730 | putative beta-ketoacyl-[acyl-carrier-pro... | 427 | Drug Target Function | March 2008 | 1J3N | 32.6% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00796 | 1 | SACOL1244 | 57285984 | fabD | malonyl CoA-acyl carrier protein transac... | 308 | Drug Target Function | March 2008 | 3EZO | 38.6% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP02724 | 1 | GBAA1330 | 47526596 | fabG | acetoacetyl-CoA reductase [Bacillus anth... | 247 | N/A | June 2008 | 2UVD | 46.6% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00304 | 1 | CBU_0038 | 29653401 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 327 | Drug Target Function | March 2008 | 1UB7 | 29.4% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP02748 | 1 | GBAA4408 | 47529702 | accC | acetyl-CoA carboxylase biotin carboxylas... | 450 | N/A | June 2008 | 2VPQ | 66.4% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00311 | 1 | CBU_0494 | 29653836 | fabD | malonyl CoA-acyl carrier protein transac... | 313 | Drug Target Function | March 2008 | 1MLA | 54% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP02367 | 1 | GBAA0213 | 47525471 | 1-acyl-sn-glycerol-3-phosphate acyltrans... | 201 | N/A | June 2008 | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||||
| IDP00426 | 1 | YPO1598 | 16121866 | fabD | acyl carrier protein S-malonyltransferas... | 309 | Conserved Gene / Pathway | March 2008 | 1MLA | 78.3% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00312 | 1 | CBU_0497 | 29653839 | fabF | 3-oxoacyl-acyl carrier protein synthase ... | 414 | Drug Target Function | March 2008 | 1B3N | 60.1% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP02782 | 1 | GBAA4874 | 161611196 | fabG | 3-ketoacyl-(acyl-carrier-protein) reduct... | 252 | N/A | June 2008 | 1WMB | 33.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00486 | 1 | YPO1463 | 16121738 | putative acyl transferase | 282 | Conserved Gene / Pathway | March 2008 | 2CUY | 35.5% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00577 | 1 | YPO2757 | 16122961 | fabB | 3-oxoacyl-(acyl carrier protein) synthas... | 407 | Virulence Associated Factor | March 2008 | 1FJ4 | 85.3% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00334 | 1 | FTT1375 | 56708428 | fabG | 3-oxoacyl-(acyl-carrier-protein) reducta... | 247 | Drug Target Function | March 2008 | 1I01 | 61.5% | Francisella tularensis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00955 | 1 | STM1192 | 16764547 | plsX | fatty acid/phospholipid synthesis protei... | 359 | Conserved Gene / Pathway | March 2008 | 1U7N | 36.5% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01441 | 1 | VC2023 | 15642025 | 3-oxoacyl-(acyl carrier protein) synthas... | 316 | Drug Target Function | March 2008 | 1EBL | 72.8% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01781 | 1 | Cj1616 | 6969022 | dapD | possible 2,3,4,5-tetrahydropyridine-2-ca... | 258 | N/A | June 2008 | 1F3O | 31.4% | Campylobacter jejuni | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00357 | 1 | lmo0885 | 16802926 | hypothetical protein lmo0885 | 118 | Drug Target Function | March 2008 | 1F7L | 50% | Listeria monocytogenes | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00962 | 1 | STM1427 | 16764775 | cfa | cyclopropane fatty acyl phospholipid syn... | 382 | Drug Target Function | March 2008 | 1KP9 | 26.7% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00352 | 1 | lmo1808 | 16803848 | fabD | acyl-carrier-protein S-malonyltransferas... | 313 | Drug Target Function | March 2008 | 1MLA | 45.4% | Listeria monocytogenes | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00353 | 1 | lmo2202 | 16804241 | 3-oxoacyl-(acyl carrier protein) synthas... | 312 | Drug Target Function | March 2008 | 1ZOW | 58.3% | Listeria monocytogenes | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01760 | 1 | Cj1354 | 6968780 | dxr | putative 1-deoxy-D-xylulose 5-phosphate ... | 251 | N/A | June 2008 | 1F3O | 32.7% | Campylobacter jejuni | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00869 | 1 | STM4235 | 16767485 | plsB | glycerol-3-phosphate acyltransferase | 806 | Essential Gene | March 2008 | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||||
| IDP00956 | 1 | STM1194 | 16764549 | fabD | acyl carrier protein S-malonyltransferas... | 309 | Essential Gene | March 2008 | 1MLA | 93.2% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00310 | 1 | CBU_0493 | 29653835 | fabH | 3-oxoacyl-(acyl-carrier-protein) synthas... | 319 | Drug Target Function | March 2008 | 1HN9 | 54.5% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00303 | 1 | CBU_0035 | 29653398 | beta-ketoacyl synthase | 424 | Drug Target Function | March 2008 | 3E60 | 37.3% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP02328 | 1 | GBAA2548 | 47527837 | acetyl-CoA carboxylase biotin carboxylas... | 445 | N/A | June 2008 | 2VPQ | 50.6% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP02407 | 1 | GBAA3988 | 47529279 | acpP | acyl carrier protein [Bacillus anthracis... | 77 | N/A | June 2008 | 1HY8 | 80.5% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00407 | 1 | YPO2929 | 16123116 | acpS | 4'-phosphopantetheinyl transferase | 126 | Virulence Associated Factor | March 2008 | 2JBZ | 42.1% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00787 | 1 | SACOL1016 | 57284388 | fabI | enoyl-(acyl carrier protein) reductase | 256 | Drug Target Function | March 2008 | 2QIO | 62.5% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01461 | 1 | VC2457 | 15642453 | acpS | 4'-phosphopantetheinyl transferase | 126 | Drug Target Function | March 2008 | 1F7L | 42.9% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01201 | 1 | BA_1826 | 34098434 | 3-oxoacyl-[acyl-carrier-protein] synthas... | 327 | Drug Target Function | March 2008 | 1ZOW | 40.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00541 | 1 | YPO1597 | 16121865 | fabH | 3-oxoacyl-(acyl carrier protein) synthas... | 316 | Conserved Gene / Pathway | March 2008 | 1HN9 | 81.3% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01493 | 1 | VCA0751 | 161582040 | 3-oxoacyl-(acyl carrier protein) synthas... | 362 | Drug Target Function | March 2008 | 2EBD | 40.9% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01213 | 1 | BA_3251 | 30257808 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 329 | Drug Target Function | March 2008 | 2EBD | 34.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01252 | 1 | BA_5623 | 30260075 | penicillin-binding protein | 683 | Drug Target Function | March 2008 | 2OLU | 27.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00016 | 1 | BA_4053 | 46576983 | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 491 | Drug Target Homolog | October 2007 | 1E8C | 35% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01188 | 1 | BA_0502 | 30254030 | penicillin-binding protein, putative | 412 | Drug Target Function | March 2008 | 2QMI | 21.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00548 | 1 | YPO0549 | 16120877 | ftsI | penicillin-binding protein 3 | 587 | Drug Target Function | March 2008 | 3EQU | 36.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00575 | 1 | YPO0557 | 16120885 | ddl | D-alanine--D-alanine ligase | 306 | Drug Target Function | March 2008 | 1IOV | 72.5% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01124 | 1 | BA_4938 | 33301353 | UDP-N-acetylmuramate--L-alanine ligase (... | 436 | Conserved Gene / Pathway | March 2008 | 2F00 | 31.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01222 | 1 | BA_4049 | 33301352 | UDP-N-acetylglucosamine--N-acetylmuramyl... | 364 | Drug Target Function | March 2008 | 1F0K | 31.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00589 | 1 | YPO0954 | 161486886 | mltC | membrane-bound lytic murein transglycosy... | 358 | Drug Target Function | March 2008 | 1QSA | 17.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00590 | 1 | YPO1078 | 16121379 | mltD | predicted membrane-bound lytic murein tr... | 475 | Drug Target Function | March 2008 | 1E0G | 7.8% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01250 | 1 | BA_4497 | 30259003 | penicillin-binding protein | 706 | Drug Target Function | March 2008 | 2Z2L | 14.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01457 | 1 | VC2407 | 15642404 | penicillin-binding protein 3 | 580 | Drug Target Function | March 2008 | 3EQU | 34% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01247 | 1 | BA_3214 | 30257780 | penicillin-binding protein, putative | 691 | Drug Target Function | March 2008 | 2QMI | 14.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01488 | 1 | VCA0572 | 15601331 | ddl | D-alanyl-alanine synthetase A | 334 | Conserved Gene / Pathway | March 2008 | 2FB9 | 34.1% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01240 | 1 | BA_1069 | 30254800 | pbpF | penicillin-binding protein 1 | 705 | Drug Target Function | March 2008 | 2OLU | 27.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00403 | 1 | YPO1125 | 16121425 | pal | peptidoglycan-associated outer membrane ... | 168 | Conserved Gene / Pathway | March 2008 | 1OAP | 58.3% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02026 | 1 | CBU_0123 | 29540743 | murE | UDP-N-acetylmuramoylalanyl-D-glutamate-2... | 489 | N/A | June 2008 | 1E8C | 41.5% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00906 | 1 | STM0129 | 16763519 | murC | UDP-N-acetylmuramate--L-alanine ligase | 491 | Essential Gene | March 2008 | 2F00 | 94.5% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00523 | 1 | YPO1224 | 16121513 | ampH | beta-lactamase/D-alanine carboxypeptidas... | 388 | Conserved Gene / Pathway | March 2008 | 2QMI | 22.2% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00417 | 1 | YPO2604 | 16122817 | pbpA | penicillin-binding protein 2 | 631 | Drug Target Function | March 2008 | 1MWR | 23.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00910 | 1 | STM0190 | 16763580 | mrcB | penicillin-binding protein 1b | 840 | Drug Target Function | March 2008 | 2OLU | 18.9% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00425 | 1 | YPO3863 | 16123998 | wecC | UDP-N-acetyl-D-mannosamine dehydrogenase... | 420 | Conserved Gene / Pathway | March 2008 | 2O3J | 29.8% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01463 | 1 | VC2514 | 15642510 | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 419 | Drug Target Function | March 2008 | 1NAW | 80.9% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00219 | 1 | YPO1938 | 16122184 | - | probable deoR-family transcriptional reg... | 256 | Virulence | October 2007 | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||||
| IDP01223 | 1 | BA_4051 | 60390084 | UDP-N-acetylmuramoylalanine--D-glutamate... | 450 | Conserved Gene / Pathway | March 2008 | 1E0D | 34.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01249 | 1 | BA_4055 | 30258562 | penicillin-binding protein | 716 | Drug Target Function | March 2008 | 1QME | 30.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00305 | 1 | CBU_0118 | 29653476 | pbpB | penicillin-binding protein 3 | 548 | Drug Target Function | March 2008 | 3EQU | 39.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00668 | 1 | SACOL1196 | 57284481 | murD | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 449 | Conserved Gene / Pathway | March 2008 | 2JFF | 31.4% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00674 | 1 | SACOL1453 | 57286104 | murG | N-acetylglucosaminyl transferase | 356 | Drug Target Function | March 2008 | 1F0K | 25.6% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00597 | 1 | Y | ||||||||||||||||||||||||||||